1. DOP53 Clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active ulcerative colitis. (25th January 2019) Authors: Sandborn, W; Nguyen, D; Ferslew, B; Hao, L-Y; Kanno, T; Tomsho, L; Boyle, D; Graham, R; Abhyankar, B; Panes, J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗